Results 21 to 30 of about 311,027 (339)
Mechanical Circulatory Assist Devices: Time for More Attention by Iranian Cardiologists
Journal of Tehran University Heart Center, 2022 -
Haleh Ashraf +2 more
doaj +1 more source
Cirugía Cardiovascular, 2022 Resumen: Introducción y objetivo: Evaluar el resultado del uso de dispositivos de asistencia ventricular de corta-media duración, tipo Centrimag e Impella, en pacientes en INTERMACS 1-3, como puente al trasplante cardiaco. Material y método: Del 2015 al
Carlos Domínguez-Massa +12 more
doaj +1 more source
An Up-to-Date Literature Review on Ventricular Assist Devices Experience in Pediatric Hearts
Life, 2022 Ventricular assist devices (VAD) have gained popularity in the pediatric population during recent years, as more and more children require a heart transplant due to improved palliation methods, allowing congenital heart defect patients and children with ...
Ștefana Maria Moisă +10 more
doaj +1 more source
Thermoplastic Elastomers: Materials for Heart Assist Devices [PDF]
Polymers in Medicine, 2016 Heart assisting devices have become a standard element in clinical practice and provide support for the traditional methods of treating heart disease. Regardless of the construction of VAD (ventricular assist devices), there are crucial requirements that have to be met by the construction materials: high purity, desired physical, chemical and ...
Agnieszka Piegat, Miroslawa El Fray
openaire +3 more sources
Factors influencing transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device. [PDF]
, 2020 BackgroundBridging heart failure patients with mechanical ventricular assist devices (VAD) enables access to transplantation. However, VAD is associated with increased risk for anti-HLA antibodies associated with rejection of subsequent allografts ...
Adler, Eric +5 more
core +1 more source
Laparoscopic sleeve gastrectomy in obese patients with ventricular assist devices: a data note
BMC Research Notes, 2020 Objectives Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight after implantation, which is associated with higher complication rates and is a contraindication for heart transplantation (HT ...
Adrian daSilva-deAbreu +10 more
doaj +1 more source
Journal of Tehran University Heart Center, 2020 The gold standard treatment for end-stage heart failure is heart transplantation; however, the rate of transplantation remains inadequate because of the paucity of organ donation.
Nevri̇ye Salman +5 more
doaj +1 more source
Mechanical Circulatory Assist Devices: Which Is the Best Device as Bridge to Heart Transplantation? [PDF]
Brazilian Journal of Cardiovascular Surgery, 2022 Introduction: Heart transplantation is the recommended treatment method for patients with advanced heart failure that is refractory to clinical treatment.
Adriana Natucci Hette +1 more
doaj +1 more source
Giant cell myocarditis masquerading as orbital myositis with a rapid, fulminant course necessitating mechanical support and heart transplantation. [PDF]
, 2017 Giant cell myocarditis (GCM), a rapidly progressive inflammation of the myocardium, is associated with fulminant heart failure, refractory ventricular arrhythmias, and conduction system abnormalities.
Aksoy, Olcay +5 more
core +1 more source
Journal of Chest Surgery, 2021 A 55-year-old woman who had received an implantable left ventricular assist device 3 months earlier presented with dyspnea and a low-flow alarm of the device.
Yoonseo Lee +5 more
doaj +1 more source